Author correction to ‘FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis’ [Acta Pharmaceutica Sinica B 14(2024)1605-1623]
Available online 9 April 2024
Author links open overlay panel, , , , , , , , , , , , , , ,
© 2024 The Author(s). Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.
留言 (0)